Login / Signup

[Post-stroke cognitive impairment in young patients].

L A ShchepankevichK V RerikhI A GribachevaT F PopovaE V TaneevaN E TyazhelnikovD V SokolovaA V Boznyakov
Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2024)
Cortexin therapy has been shown to be effective, safe and well tolerated in young people with cognitive deficits in the poststroke period.
Keyphrases
  • cognitive impairment
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • patient reported outcomes
  • mesenchymal stem cells
  • upper limb
  • patient reported